Immediate Impact
51 standout
Citing Papers
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019
2024 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of Marisol Martínez being referenced
Real‐world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta‐analysis
2017
99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b-Infected Patients Treated With Label-Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marisol Martínez | 146 | 103 | 50 | 19 | 239 | |
| Maria Letícia Santos Cruz | 149 | 99 | 56 | 24 | 292 | |
| Anna Degli Antoni | 138 | 55 | 49 | 22 | 209 | |
| Laura Bamford | 161 | 117 | 32 | 33 | 250 | |
| Kathleen George | 222 | 102 | 39 | 19 | 296 | |
| Aneth Vedastus Kalinjuma | 155 | 115 | 79 | 20 | 246 | |
| Charles S. Chasela | 110 | 121 | 38 | 20 | 283 | |
| Zunaid Barday | 149 | 57 | 34 | 16 | 253 | |
| Kimberley Brown | 216 | 59 | 55 | 28 | 272 | |
| Jennifer Legardy-Williams | 87 | 75 | 21 | 16 | 246 | |
| Xi He | 210 | 91 | 17 | 13 | 269 |
All Works
Loading papers...